'Net sales (including other operating income) of Advanced Enzyme Technologies has declined 7.44% to Rs 146.1 crore.  The total revenue from operations de-grew by 7% on y-o-y basis and 5% on q-o-q basis. The revenue from human nutrition segment decreased by 6% to Rs 99.2 crore in Q2 FY25 as compared to Rs 105.9 crore in Q2 FY24. The Animal nutrition delivered a growth of 5% to Rs 18.1 crore in Q2 FY25 as against Rs 17.3 crore in Q2 FY24. The Bio-Processing segment underperformed by 31% during the quarter, it accounted for Rs 16.8 crore in Q2 FY25 as compared to Rs 24.3 crore in Q2 FY24. In this segment, food business de-grew by 42% to Rs 11.6 crore on y-o-y basis during Q2 FY25. The Non-Food business grew by 24% to stood at Rs 5.1 crore during thequarter. The Specialized manufacturing segment contributed 8% in the pie which is around Rs 12 crore to the revenue during the quarter, an increase of 17% on y-o-y basis.

• 

  (01-Mar-2025)

  Foseco India

  OP up 17%
• 

  (28-Feb-2025)

  Schaeffler India

  Maintains double digit revenue growth and stable OPM
• 

  (28-Feb-2025)

  Sanofi India

  OP up 18.78%
• 

  (28-Feb-2025)

  KSB

  Net up 33% largely on higher sales, higher OI and lower taxation